: Clinical trials and experimental stages on the German-American vaccine did not include only healthy young people, but also included people with immune diseases, rheumatic diseases and diseases such as asthma and COPD. All of these groups were able to tolerate the vaccine and can be given the vaccine. Those with chronic diseases should also be part of the vaccination campaign. Those who receive fluids must be treated even though the needle of the syringe is very thin and does not usually cause bleeding. The important thing, although the subject of an allergic reaction is rare, is that the person stays for a short time and is monitored until treatment is done immediately if an allergic reaction occurs.
Quoted from Dr. Thomas Grunwald, head of the vaccination committee in Saxony, Germany